课题基金 / 基金详情

Analysis of cardiovascular function with mutant mice lacking for single or multiple alpha 1 adrenergic receptor.

Analysis of cardiovascular function with mutant mice lacking for single or multiple alpha 1 adrenergic receptor.
缺乏单个或多个 α1 肾上腺素受体的突变小鼠的心血管功能分析。
批准号:
17500296
负责人:
TANOUE Akito
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

TANOUE Akito的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To study the functional role of individual alpha1-adrenergic (AR) subtypes in blood pressure (BP) regulation, we used mice lacking the alpha1B-AR and/or alpha1D-AR with the same genetic background and further studied their hemodynamic and vasoconstrictive responses. Both the alpha1B-AR knockout and alpha1B-/alpha1D-AR double knockout mice, but not the alpha1A-AR knockout mice, had significantly (p < 0.05) lower levels of basal systolic and mean arterial BP than wild-type mice in non-anesthetized condition, and they showed no significant change in heart rate or in cardiac function, as assessed by echocardiogram. Furthermore, triple knockout of three subtypes showed reduced blood pressure. All mutants showed a significantly (p < 0.05) reduced catecholamine-induced pressor and vasoconstriction responses. It is noteworthy that the infusion of norepinephrine did not elicit any pressor response at all in alpha1B-/alpha1D-AR double knockout mice. In an attempt to further examine alpha1-AR subtype, which is involved in the genesis or maintenance of hypertension, BP after salt loading was monitored by tail-cuff readings and confirmed at the endpoint by direct intra-arterial recording. After salt loading, alpha1B-AR knockout mice developed a comparable level of hypertension to wild-type mice, whereas mice lacking alpha1D-AR had significantly (p < 0.05) attenuated BP and lower levels of circulating catecholamines. Our data indicated that alpha1B-and alpha1D-AR subtypes participate cooperatively in BP regulation ; however, the deletion of the functional alpha1D-AR, not alpha1B-AR, leads to an antihypertensive effect. The study shows differential contributions of alpha1B-and alpha1D-ARs in BP regulation.
期刊论文(23)
专著(0)
科研奖励(0)
会议论文
Evidence for involvement of alpha(1D)-adrenoceptors in contraction of femoral resistance arteries using knockout mice.
使用基因敲除小鼠证明 α(1D)-肾上腺素受体参与股动脉阻力动脉收缩的证据。
DOI: --
发表时间: 2005
期刊: Br.J.Pharmacol. 146
影响因子: --
作者: [M.Isaji et al., H.Wang et al., N.Yamada et al., H.Ueno et al., H.Tanahashi et al., Okuno Y, Adachi T, Ishida A, Hosoda C, Zhu S, Lazaro-Suarez ML, Kagaya S, Zacharia J]
通讯作者: Zacharia J
DOI: 10.1016/j.bcp.2006.11.002
发表时间: 2007-04-15
期刊: BIOCHEMICAL PHARMACOLOGY
影响因子: 5.8
作者: [Koshimizu, Taka-aki, Tanoue, Akito, Tsujimoto, Gozoh]
通讯作者: Tsujimoto, Gozoh
Chloroethylclonidine reveals that alpha(1A)-adrenoceptors mediate contraction in aorta of alpha(1D)-adrenoceptor knockout mice.
氯乙基可乐定揭示 α(1A)-肾上腺素受体介导 α(1D)-肾上腺素受体基因敲除小鼠的主动脉收缩。
DOI: --
发表时间: 2005
期刊: Auton Autacoid Pharmacol. 25
影响因子: --
作者: [Lazaro-Suarez ML, Gomez-Zamudio JH, Gallardo-Ortiz IA, Tanoue A, Tsujimoto G, Farias-Rodriguez VM, Villalobos-Molina R]
通讯作者: Villalobos-Molina R
DOI: 10.1038/sj.bjp.0706325
发表时间: 2005-10-01
期刊: BRITISH JOURNAL OF PHARMACOLOGY
影响因子: 7.3
作者: [Hosoda, C, Tanoue, A, Koike, K]
通讯作者: Koike, K
13
    Development of humanized-liver mice using hepatocyte derived from pediatric liver/biliary tract diseases and investigation of pathological mechanism of liver/biliary tract diseases.
    Development of humanized-liver mice using hepatocyte derived from isolated liver tissue from recipient or donor of living donor liver transplantation
    Analysis of urogenital function with mutant mice lacking for single or multiple alpha 1 adrenergic receptor.
    In vitro analysis of signaling pathway involved in pathgenesis of renal or cardiac disease using animal models.
    海外基金